There are 7 papers on mixed dyslipidemia in aging research: 4 trials and 3 observational studies in people.
7 papers study it5 more mention it1 finding
5 new papers in 30 daysSee all 12
“remitting the diagnosis of mixed dyslipidemia in 90% of the patients.”
- Human trial4
- Humans3
Associations
1Berberine + bezafibrate
downin humans1−90%
1 study
Berberine + bezafibrate
downin humans1−90%
Berberine + bezafibrate lowers the risk of mixed dyslipidemia in humans (mixed dyslipidemia) (90%).
“remitting the diagnosis of mixed dyslipidemia in 90% of the patients.”
Human trialmixed dyslipidemia90 daysn = 36
Journal of medicinal food
Trial sponsors
Company1 trialPhase 4328 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 465 people
Company7 trialsPhase 35,678 people
Company4 trialsPhase 35,942 people
Company3 trialsPhase 3701 people
Company2 trialsPhase 3409 people
A. Menarini International Licensing
Company1 trialPhase 3426 people
Company1 trialPhase 3103 people
Latest
8 papers in 12 monthsESC Congress 2026 Abstract
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
Randomized trial in 156 peopleInterventions
ESC Congress 2026 Abstract
Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study
Cross-sectional study of 814,451 peopleHypercholesterolemia
ESC Congress 2026 Abstract
Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study
Cohort study of 960 peopleBempedoic acid
ESC Congress 2026 Abstract
The effects of STAtin-FENOfibrate combination therapy vs. statin monotherapy on necrotic core and plaque characteristics in non-diabetic patients with combined dyslipidemia and intermediate CAOD
Randomized trial in 79 peopleStatins
AHA Scientific Sessions 2025 Abstract
RNA INTERFERENCE OF ANGPTL3 VIA ZODASIRAN: A NEXT-GENERATION APPROACH FOR TREATING ATHEROGENIC DYSLIPIDEMIA
Cohort study in peopleAtherogenic dyslipidemia
Journal of Medicinal Food
Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial
Randomized trial in 36 peopleBerberine
Journal of Hypertension
Prevalence and influencing factors of masked uncontrolled hypertension among Chinese female patients with clinically controlled hypertension
Cross-sectional study of 10,527 peopleHypertension
Journal of Cystic Fibrosis
Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis
Study in peoplePopulations